betaine hydrochloride 25 MG / folic acid 5 MG / mecobalamin 1 MG / pyridoxine 100 MG Oral Capsule

RxCUI
1144761
RxNorm name
betaine hydrochloride 25 MG / folic acid 5 MG / mecobalamin 1 MG / pyridoxine 100 MG Oral Capsule
Display name
Betaine/Folic acid/Mecobalamin/Pyridoxine (Oral Pill)
Full name
betaine hydrochloride 25 MG / folic acid 5 MG / mecobalamin 1 MG / pyridoxine 100 MG Oral Capsule
Term type
SCD
Status
Active
Strength
25-5-1-100 mg
Dose form
Cap
Route
Oral Pill
Updated
2026-10-26 03:53:26

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092011
Active start
092011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
betaine hydrochloride25 MG / 1 EACHbetainebetaine hydrochloride
mecobalamin1 MG / 1 EACHmecobalaminmecobalamin
folic acid5 MG / 1 EACHfolic acidfolic acid
pyridoxine100 MG / 1 EACHpyridoxinepyridoxine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
betaine1512
mecobalamin29421
folic acid4511
pyridoxine684879

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
53191024801rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA09ABAcid preparationsATC1-4betaine hydrochloride
ATCA16AAAmino acids and derivativesATC1-4betaine
ATCB03BBFolic acid and derivativesATC1-4folic acid
ATCV04CXOther diagnostic agentsATC1-4folic acid
ATCA11HAOther plain vitamin preparationsATC1-4pyridoxine
ATCB03BAVitamin B12 (cyanocobalamin and analogues)ATC1-4mecobalamin
FDASPLD025101Vitamin B 6CHEMhas_chemical_structurepyridoxine
FDASPLN0000175805Methylating AgentEPChas_epcbetaine
FDASPLN0000192800Vitamin B6 AnalogEPChas_epcpyridoxine
FDASPLN0000175804Methylating ActivityMOAhas_moabetaine
MEDRTD001622BetaineCHEMhas_ingredientbetaine
MEDRTD001622BetaineCHEMhas_ingredientbetaine hydrochloride
MEDRTD005492Folic AcidCHEMhas_ingredientfolic acid
MEDRTD011736PyridoxineCHEMhas_ingredientpyridoxine
MEDRTD014805Vitamin B 12CHEMhas_ingredientmecobalamin
MEDRTD020269Alcoholic NeuropathyDISEASEmay_treatmecobalamin
MEDRTD000741Anemia, AplasticDISEASEci_withfolic acid
MEDRTD018798Anemia, Iron-DeficiencyDISEASEci_withfolic acid
MEDRTD000749Anemia, MegaloblasticDISEASEmay_treatfolic acid
MEDRTD000752Anemia, PerniciousDISEASEci_withfolic acid
MEDRTD000752Anemia, PerniciousDISEASEmay_treatmecobalamin
MEDRTD003929Diabetic NeuropathiesDISEASEmay_treatmecobalamin
MEDRTD004342Drug HypersensitivityDISEASEci_withmecobalamin
MEDRTD004342Drug HypersensitivityDISEASEci_withfolic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withbetaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withpyridoxine
MEDRTD004342Drug HypersensitivityDISEASEci_withbetaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventpyridoxine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatpyridoxine
MEDRTD005494Folic Acid DeficiencyDISEASEmay_preventfolic acid
MEDRTD005494Folic Acid DeficiencyDISEASEmay_treatfolic acid
MEDRTD006712HomocystinuriaDISEASEmay_treatbetaine hydrochloride
MEDRTD006712HomocystinuriaDISEASEmay_treatbetaine
MEDRTD009103Multiple SclerosisDISEASEmay_treatmecobalamin
MEDRTD009436Neural Tube DefectsDISEASEmay_preventfolic acid
MEDRTD012640SeizuresDISEASEmay_treatpyridoxine
MEDRTD014806Vitamin B 12 DeficiencyDISEASEmay_preventmecobalamin
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_preventpyridoxine
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_treatpyridoxine
MEDRTN0000000163Enzyme InteractionsMOAhas_moafolic acid
MEDRTN0000000163Enzyme InteractionsMOAhas_moapyridoxine
MEDRTN0000000163Enzyme InteractionsMOAhas_moamecobalamin
MEDRTN0000008337Cellular Activity AlterationPEhas_pepyridoxine
MEDRTN0000008337Cellular Activity AlterationPEhas_pemecobalamin
MEDRTN0000008337Cellular Activity AlterationPEhas_pefolic acid
MEDRTN0000009065Hematologic Activity AlterationPEhas_pebetaine
MEDRTN0000009065Hematologic Activity AlterationPEhas_pebetaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH25 MG / 5 MG / 1 MG / 100 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
SOURCESSourceMicromedex RED BOOK